Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2026-01-02 @ 1:29 AM
Study NCT ID:
NCT01360593
Status:
COMPLETED
Last Update Posted:
2022-03-08
First Post:
2011-05-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma
Sponsor:
David A. Clump, MD, PhD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
08-139
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None